Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 17, 2022

SELL
$74.28 - $92.69 $2.29 Million - $2.86 Million
-30,850 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$74.77 - $85.47 $336,465 - $384,615
-4,500 Reduced 12.73%
30,850 $2.38 Million
Q1 2021

May 17, 2021

BUY
$74.73 - $90.69 $149,460 - $181,380
2,000 Added 6.0%
35,350 $2.67 Million
Q4 2020

Feb 16, 2021

BUY
$72.61 - $90.2 $486,487 - $604,340
6,700 Added 25.14%
33,350 $2.92 Million
Q3 2020

Nov 16, 2020

BUY
$71.87 - $131.03 $1.92 Million - $3.49 Million
26,650 New
26,650 $2.03 Million

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.2B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Birch Grove Capital LP Portfolio

Follow Birch Grove Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Birch Grove Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Birch Grove Capital LP with notifications on news.